Selene Systems

Selene (officially Selene Systems, Inc.) is a New York-based biotechnology company pioneering the development of programmable RNA medicines using advanced deep learning. Founded by leaders in computational biology, the company leverages its proprietary "Selene" platform to predict how genetic variations influence RNA processing and function. By integrating large-scale genomic data with machine learning, Selene aims to design highly specific RNA-based therapeutics for a variety of diseases, including rare genetic disorders and oncology. The company is backed by prominent investors such as GV (Google Ventures) and Casdin Capital. Selene is currently in the early stages of drug discovery, utilizing its platform to identify novel targets and optimize RNA-based drug candidates.